NASDAQ:TMDI Titan Medical - TMDI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Titan Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.91 +0.05 (+5.84%) (As of 01/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.85▼$0.9350-Day Range$0.39▼$1.0152-Week Range$0.38▼$1.20Volume88,379 shsAverage Volume426,256 shsMarket Capitalization$101.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Titan Medical (NASDAQ:TMDI) StockTitan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.Read More Receive TMDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address TMDI Stock News HeadlinesJanuary 9, 2023 | finance.yahoo.comTitan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference WeekDecember 28, 2022 | finance.yahoo.comTitan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request HearingJanuary 31, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.December 6, 2022 | bizjournals.comChapel Hill medtech furloughs staff as it weighs potential saleDecember 6, 2022 | finance.yahoo.comTitan Medical Implements Cost-Cutting Measures to Support Strategic Review ProcessNovember 30, 2022 | bizjournals.comChapel Hill public company could be looking for a buyer soonNovember 30, 2022 | markets.businessinsider.comTitan Medical To Evaluate Strategic AlternativesNovember 30, 2022 | finance.yahoo.comTitan Medical Announces Commencement of Strategic Review ProcessJanuary 31, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…November 16, 2022 | finance.yahoo.comTitan Medical Third Quarter 2022 Earnings: US$0.093 loss per share (vs US$0.077 loss in 3Q 2021)November 10, 2022 | finanznachrichten.deTitan Medical Inc.: Titan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder MeetingNovember 10, 2022 | seekingalpha.comTitan Medical Inc. (TMDI) Q3 2022 Earnings Call TranscriptNovember 10, 2022 | finance.yahoo.comTitan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder MeetingNovember 2, 2022 | finance.yahoo.comTitan Medical to Issue Third Quarter 2022 Financial Results on November 10, 2022September 22, 2022 | finance.yahoo.comTitan Medical Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted SurgerySeptember 14, 2022 | bizjournals.comChapel Hill firm extends partnership with $30B medical device giantAugust 11, 2022 | seekingalpha.comTitan Medical Inc. (TMDI) CEO Cary Vance on Q2 2022 Results - Earnings Call TranscriptJuly 25, 2022 | finance.yahoo.comTitan Medical to Issue Second Quarter 2022 Financial Results on August 11, 2022July 10, 2022 | bizjournals.comNew Titan Medical CEO tasked with keeping Chapel Hill firm on track to commercializationJuly 1, 2022 | finance.yahoo.comChapel Hill company given extension to regain Nasdaq complianceJune 29, 2022 | seekingalpha.comTitan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price ruleJune 29, 2022 | finance.yahoo.comTitan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleJune 21, 2022 | seekingalpha.comTitan teams up with Nissha Medical to advance Enos surgical systemJune 1, 2022 | finance.yahoo.comTitan Medical Announces Executive DepartureMay 12, 2022 | seekingalpha.comTitan Medical Inc. (TMDI) CEO Paul Cataford on Q1 2022 Results - Earnings Call TranscriptMay 12, 2022 | seekingalpha.comTitan Medical reports Q1 resultsMay 12, 2022 | finance.yahoo.comTitan Medical Reports Financial Results for the First Quarter 2022See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TMDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Titan Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address TMDI Company Calendar Last Earnings11/10/2022Today1/31/2023Next Earnings (Estimated)3/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TMDI CUSIPN/A CIK840551 Webwww.titanmedicalinc.com Phone(416) 548-7522FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,860,000.00 Net MarginsN/A Pretax Margin-209.87% Return on Equity-167.03% Return on Assets-112.15% Debt Debt-to-Equity RatioN/A Current Ratio1.41 Quick Ratio1.41 Sales & Book Value Annual Sales$10 million Price / Sales10.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.32 per share Price / Book2.83Miscellaneous Outstanding Shares111,954,000Free Float111,932,000Market Cap$101.49 million OptionableNot Optionable Beta2.14 Key ExecutivesCary Guy VancePresident, Chief Executive Officer & DirectorBill FaheyVice President-Manufacturing & OperationsStephen L. LemieuxChief Financial OfficerDeepak BasraVice President-Strategy & Business DevelopmentChien HuangVice President-FinanceKey CompetitorsNeuroPaceNASDAQ:NPCELyra TherapeuticsNASDAQ:LYRACo-DiagnosticsNASDAQ:CODXApyx MedicalNASDAQ:APYXNeovascNASDAQ:NVCNView All CompetitorsInsiders & InstitutionsEssex LLCBought 493,422 shares on 1/31/2023Ownership: 2.553%Kingsbury Capital Investment Advisors LLCBought 178,939 shares on 11/10/2022Ownership: 0.200%Essex LLCBought 359,581 shares on 11/7/2022Ownership: 2.113%View All Institutional Transactions TMDI Stock - Frequently Asked Questions Should I buy or sell Titan Medical stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" TMDI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TMDI, but not buy additional shares or sell existing shares. View TMDI analyst ratings or view top-rated stocks. How have TMDI shares performed in 2023? Titan Medical's stock was trading at $0.6606 at the start of the year. Since then, TMDI shares have increased by 37.2% and is now trading at $0.9065. View the best growth stocks for 2023 here. When is Titan Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023. View our TMDI earnings forecast. How were Titan Medical's earnings last quarter? Titan Medical Inc. (NASDAQ:TMDI) posted its quarterly earnings results on Thursday, November, 10th. The company reported ($0.09) earnings per share for the quarter. What other stocks do shareholders of Titan Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Titan Medical investors own include NIO (NIO), Advanced Micro Devices (AMD), Electrameccanica Vehicles (SOLO), Sorrento Therapeutics (SRNE), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), Micron Technology (MU), Blink Charging (BLNK), Bionano Genomics (BNGO) and FuelCell Energy (FCEL). What is Titan Medical's stock symbol? Titan Medical trades on the NASDAQ under the ticker symbol "TMDI." Who are Titan Medical's major shareholders? Titan Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Essex LLC (2.55%). How do I buy shares of Titan Medical? Shares of TMDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Titan Medical's stock price today? One share of TMDI stock can currently be purchased for approximately $0.91. How much money does Titan Medical make? Titan Medical (NASDAQ:TMDI) has a market capitalization of $101.49 million and generates $10 million in revenue each year. The company earns $-14,860,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. How can I contact Titan Medical? Titan Medical's mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The official website for the company is www.titanmedicalinc.com. The company can be reached via phone at (416) 548-7522. This page (NASDAQ:TMDI) was last updated on 1/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.